Affymax Sees NDA Filing for Anemia Treatment Hematide in 2011

Drug Industry Daily
A A
Affymax and its partner Takeda Pharmaceutical plan on submitting an NDA for their anemia candidate Hematide in the first half of 2011, but will limit the indication to treat dialysis patients only.

To View This Article:

Login

Subscribe To Drug Industry Daily